These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
716 related items for PubMed ID: 16361544
1. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA. Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8606-14. PubMed ID: 16361544 [Abstract] [Full Text] [Related]
2. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. Krengel S, Grotelüschen F, Bartsch S, Tronnier M. J Cutan Pathol; 2004 Jan 15; 31(1):1-7. PubMed ID: 14675278 [Abstract] [Full Text] [Related]
3. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Sanders DS, Blessing K, Hassan GA, Bruton R, Marsden JR, Jankowski J. Mol Pathol; 1999 Jun 15; 52(3):151-7. PubMed ID: 10621837 [Abstract] [Full Text] [Related]
4. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Saldanha G, Ghura V, Potter L, Fletcher A. Br J Dermatol; 2004 Jul 15; 151(1):157-64. PubMed ID: 15270885 [Abstract] [Full Text] [Related]
5. WNT5A expression increases during melanoma progression and correlates with outcome. Da Forno PD, Pringle JH, Hutchinson P, Osborn J, Huang Q, Potter L, Hancox RA, Fletcher A, Saldanha GS. Clin Cancer Res; 2008 Sep 15; 14(18):5825-32. PubMed ID: 18794093 [Abstract] [Full Text] [Related]
6. E-cadherin/catenin complex in benign and malignant melanocytic lesions. Silye R, Karayiannakis AJ, Syrigos KN, Poole S, van Noorden S, Batchelor W, Regele H, Sega W, Boesmueller H, Krausz T, Pignatelli M. J Pathol; 1998 Dec 15; 186(4):350-5. PubMed ID: 10209482 [Abstract] [Full Text] [Related]
7. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays. Bauer R, Wild PJ, Meyer S, Bataille F, Pauer A, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK. J Clin Pathol; 2006 Jul 15; 59(7):699-705. PubMed ID: 16565225 [Abstract] [Full Text] [Related]
8. Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma. Zuidervaart W, Pavey S, van Nieuwpoort FA, Packer L, Out C, Maat W, Jager MJ, Gruis NA, Hayward NK. Melanoma Res; 2007 Dec 15; 17(6):380-6. PubMed ID: 17992121 [Abstract] [Full Text] [Related]
9. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Chetty R, Serra S, Asa SL. Am J Surg Pathol; 2008 Mar 15; 32(3):413-9. PubMed ID: 18300809 [Abstract] [Full Text] [Related]
10. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA. Clin Cancer Res; 2003 Aug 15; 9(9):3383-8. PubMed ID: 12960126 [Abstract] [Full Text] [Related]
11. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. Slipicevic A, Holm R, Emilsen E, Ree Rosnes AK, Welch DR, Mælandsmo GM, Flørenes VA. BMC Cancer; 2012 Feb 22; 12():73. PubMed ID: 22356677 [Abstract] [Full Text] [Related]
12. Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome. Flørenes VA, Maelandsmo GM, Holm R, Reich R, Lazarovici P, Davidson B. Am J Clin Pathol; 2004 Sep 22; 122(3):412-20. PubMed ID: 15362372 [Abstract] [Full Text] [Related]
13. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors. de la Fouchardière A, Caillot C, Jacquemus J, Durieux E, Houlier A, Haddad V, Pissaloux D. Virchows Arch; 2019 May 22; 474(5):539-550. PubMed ID: 30756182 [Abstract] [Full Text] [Related]
14. Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma. Tucci MG, Lucarini G, Brancorsini D, Zizzi A, Pugnaloni A, Giacchetti A, Ricotti G, Biagini G. Br J Dermatol; 2007 Dec 22; 157(6):1212-6. PubMed ID: 17970806 [Abstract] [Full Text] [Related]
15. Impact of E-cadherin expression pattern in melanocytic nevi and cutaneous malignant melanoma. Seleit IA, Samaka RM, Basha MA, Bakry OA. Anal Quant Cytopathol Histpathol; 2012 Aug 22; 34(4):204-13. PubMed ID: 23016467 [Abstract] [Full Text] [Related]
16. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations. Demunter A, Libbrecht L, Degreef H, De Wolf-Peeters C, van den Oord JJ. Mod Pathol; 2002 Apr 22; 15(4):454-61. PubMed ID: 11950921 [Abstract] [Full Text] [Related]
17. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma. Perez-Ordonez B, Huynh NN, Berean KW, Jordan RC. J Clin Pathol; 2004 Oct 22; 57(10):1080-3. PubMed ID: 15452164 [Abstract] [Full Text] [Related]
18. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma]. Cao YC, Yang F, Liu XH, Xin X, Wang CC, Geng M. Zhonghua Zhong Liu Za Zhi; 2012 Sep 22; 34(9):674-8. PubMed ID: 23159080 [Abstract] [Full Text] [Related]
19. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR. Cho-Vega JH, Vega F, Schwartz MR, Prieto VG. J Cutan Pathol; 2007 Jul 22; 34(7):535-42. PubMed ID: 17576332 [Abstract] [Full Text] [Related]
20. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance. Prgomet Z, Andersson T, Lindberg P. Eur J Oral Sci; 2017 Aug 22; 125(4):237-246. PubMed ID: 28603941 [Abstract] [Full Text] [Related] Page: [Next] [New Search]